Apperta Foundation CIC
Apperta provides clinically led governance and support for open digital health programmes. Its OpenEyes ophthalmology record system is a concrete shared-code tool; its wider work promotes interoperable clinical information.
90% of weighted axes reviewed. A mechanism hypothesis, not proven effectiveness or a donation recommendation.
Who this work enables
Tools & support for charities: OpenEyes and shared clinical-platform governance can help public-interest care providers reuse record-system infrastructure instead of commissioning every component separately.
Open-source evidence · license checked
- OpenEyes community edition — GNU AGPL v3 license file. Organization’s role: steward.
Apperta leads the collaborative OpenEyes project; hospitals, companies and individuals also contribute. AGPL v3 applies to the inspected community repository, not every module, documentation, patient data, clinical safety case, warranty or paid implementation partner. License-file snapshot:d84b0649aadeb1edd70ead5a1fc9c9725215ad1f.
License checked 2026-10-28. This is not a security audit, proof of current support or effectiveness, or a promise of free hosting. A sponsor or steward is not necessarily the sole developer. Unchecked profiles are not evidence of closed code. No extra score points are added.
Humanity’s Checklist source match
Coordination · Gatekeepers — editorial, partial alignment.
Shared clinical information and supplier-independent building blocks partially address coordination and who can build care infrastructure. Clinical and community decision rights still need separate evidence.
Explicit checklist adoption: not verified. A mechanism match is not an affiliation, endorsement, evidence of effectiveness or a scoring bonus. Read the practice.
Focus classification: 2026-10-28. Based on the organization’s dated official sources below; earlier axis-review dates are unchanged.
Compare alternatives for a funder →
The proposed pathway
Govern shared clinical software and open-platform standards
Six dimensions, with rationale
Structural depth
3 / 4Governance of interoperable clinical platforms aims to reduce fragmented systems and dependence on individual suppliers, rather than funding only one episode of care.
Institutional reach
3 / 4Shared programmes and clinical committees can influence multiple providers; website deployment figures were not independently audited or treated as measured reach.
Durability
3 / 4Open code and shared clinical models can remain reusable across supplier changes, but safety assurance, maintenance and implementation support must continue.
Scalability
4 / 4Reusable clinical software and standards allow multiple organizations to build on the same base; integration, training and specialist assurance remain local constraints.
Funding additionality
UnreviewedUnknown: project activity and stated funding needs do not establish a current marginal funding gap, delivery capacity or what additional unrestricted donations would change.
Community agency
UnreviewedUnknown: participatory design and community-oriented governance do not by themselves establish affected people’s binding authority over budgets, priorities, deployment or withdrawal.
Evidence and selection
Primary-source mechanism and identity documentation; no independent impact validation in this review
Illustrative inclusion to examine this mechanism. Inclusion is not an external recommendation or a verified comparative ranking.
A testable next question
When an eye-care provider adopts OpenEyes with appropriate local assurance, does it sustain interoperable record access and reduce avoidable workflow duplication across a supplier change without increasing clinical or privacy incidents?
Review confidence: Low–medium for the documented mechanism; low for causal effectiveness and donation comparisons. Apperta Foundation CIC’s open-platform governance and the specifically inspected OpenEyes community-edition repository; not an independent OpenEyes charity or all Apperta software licenses.
What remains uncertain
The Apperta Foundation C.I.C. is company 09483987, an active private company limited by guarantee without share capital and a Community Interest Company; it is not presented here as a registered charity or a tax-deductible donation recipient. Its current site describes it as not-for-profit. The OpenEyes community-edition repository’s AGPL v3 license is checked separately from all other Apperta products. The repository warns that the community release may lag development, has no GitHub support SLA and is not guaranteed safe clinically without local assessment. Neither open code nor clinical leadership establishes patient control, safety, free professional services or independently demonstrated benefit.
Sources to inspect
- Apperta — current not-for-profit identity, programmes and committees ↗
official · checked 2026-10-28 - Companies House — Apperta Foundation CIC, company 09483987 ↗
official · checked 2026-10-28 - OpenEyes community edition — repository, README and archive status ↗
official · checked 2026-10-28 - OpenEyes community edition — inspected GNU AGPL v3 license file ↗
official · checked 2026-10-28
Propose a sourced correction →
Axis review: 2026-10-28 · weighting method v0.2 (2026-10-26) · Method, conflicts and coverage